Table 1 Patient characteristics

From: Tumor-targeted top1 inhibitor delivery with optimized parp inhibition in advanced solid tumors: a phase i trial of gapped scheduling

Characteristic

N = 24 (%)

Gender

 Female

15 (63)

 Male

9 (37)

Median (range) age in years

59 (48–76)

ECOG performance status

 0

2 (8)

 1

22 (92)

Tumor type

 Non-small cell lung cancer

4

 Small cell carcinoma

3

 Pancreatic adenocarcinoma

3

 Cholangiocarcinoma

3

 Ovarian/ fallopian tube cancer

3

 Cervical carcinoma

2

 Colorectal carcinoma

2

 Mesothelioma

2

 Myxofibrosarcoma

1

 Thymic carcinoma

1

Received prior systemic therapy

24 (100)

 Median number of prior therapies (range)

3 (1–7)